Tenax Therapeutics (TENX) Notes Payables (2011 - 2024)
Tenax Therapeutics recorded quarterly Notes Payables of $278802.0 in Q2 2024, down 32.52% quarter-over-quarter from $413174.0 in Q1 2024, and down 19.36% year-over-year from $345749.0 in Q3 2023.
Tenax Therapeutics' Notes Payables history runs 8 years deep, the most recent figure standing at $278802.0 for Q2 2024.
- In Q2 2024, Notes Payables fell 19.36% year-over-year to $278802.0; the TTM figure through Jun 2024 stood at $278802.0 (down 19.36% YoY), while the FY2023 annual figure was $501000.0, down 19.75% from the prior year.
- Notes Payables came in at $278802.0 for Q2 2024 at Tenax Therapeutics, down from $413174.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $624302.0 in Q4 2022 to a low of $30900.0 in Q3 2020.
- A 5-year average of $314957.4 and a median of $278802.0 in 2024 frame the typical range for Notes Payables.
- On a YoY basis, Notes Payables climbed as much as 276.33% in 2023 and fell as far as 19.75% in 2023.
- Tenax Therapeutics' Notes Payables stood at $120491.0 in 2020, then surged by 77.26% to $213577.0 in 2021, then jumped by 192.31% to $624302.0 in 2022, then retreated by 19.75% to $501000.0 in 2023, then slumped by 44.35% to $278802.0 in 2024.
- According to Business Quant data, Notes Payables over the past three periods registered $278802.0, $413174.0, and $501000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 278,802.00 |
| Mar 31, 2024 | 413,174.00 |
| Dec 31, 2023 | 501,000.00 |
| Sep 30, 2023 | 624,302.00 |
| Jun 30, 2023 | 345,749.00 |
| Mar 31, 2023 | 513,906.00 |
| Dec 31, 2022 | 624,302.00 |
| Jun 30, 2022 | 91,875.00 |
| Mar 31, 2022 | 228,762.00 |
| Mar 31, 2021 | 213,577.00 |
| Dec 31, 2020 | 120,491.00 |
| Sep 30, 2020 | 30,900.00 |
| Jun 30, 2020 | 107,606.00 |
| Apr 30, 2013 | 57,539.00 |
| Jan 31, 2013 | 98,657.00 |
| Oct 31, 2012 | 7,195.00 |
| Jul 31, 2012 | 21,223.00 |
| Apr 30, 2012 | 62,958.00 |
| Jan 31, 2012 | 104,178.00 |
| Oct 31, 2011 | 7,195.00 |
| Jul 31, 2011 | 16,299.00 |
| Apr 30, 2011 | 43,295.00 |